P1 | P2 | P3 | P4 | P5 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
8 yrs, 6 mo[Battini, 2007] | 5 yrs, 5 mo[Battini, 2011] | 21 mo[Schiaffino, 2005] | 5 yrs[Mancardi, 2007] | 17 yrs | ||||||
Clinical picture at diagnosis | moderate mental retardation, severe language deficit withoral–motor dyspraxia, epilepsy, temper tantrums, clumsiness | mild mental retardation, language deficit | severe mental retardation, impairment in social interaction, epilepsy and language deficit | moderate mental retardation, epilepsy, language deficit | severe mental retardation, language deficit, epilepsy | |||||
Type of seizures | sporadic occipital seizures | two episods of febrile convulsions at 3 and 4 yrs | myoclonic seizures (2 yrs) asymmetrical spasms at 8.5 yrs | severe epilepsy with SE and polymorphic seizures (generalized, focal, myoclonic); followed by sporadic GTCS | secondarygeneralized FS at onset; apparently primary GTCS from 8 to 16 yrs | |||||
Urinary molar Cr to Crn ratio and Cr uptake* | Cr/Crn ratio: 2.35 (n.v. < 1.0) Cr uptake absent | Cr/Crn ratio: 3.08 (n.v. < 1.0) Cr up take absent | Cr/Crn ratio: 3.6 (n.v. 0.006-1.2) Cr uptake absent | Cr/Crn ratio:1.83 (n.v. 0.03-0.92) Cr uptake absent | Cr/Crn ratio: 2981 μmol Cr/mmol Crn(n.v. 22–1273) Cr uptake absent | |||||
SLC6A8 mutation | c. 1006–1008 del AAC (de novo) | c.757 G > C (inherited) | IVS1-2A > G (inherited) | c.1631 C > T (inherited) | c. 1006–1008 del AAC (inherited) | |||||
MRI | slight white matter hyperintensity in paratrigonal region | normal | white matter hyperintensity in the posterior regions | normal | white matter hyperintensity in the posterior regions | |||||
MRS | PCr/PDE | tCr | PCr/PDE | tCr | PCr/PDE | tCr | PCr/PDE | tCr | PCr/PDE | tCr |
n.v.1.40 ± 0.07 | n.v.4.37 ± 0.34 | n.v.1.40 ± 0.07 | n.v.4.37 ± 0.34 | n.v.1.40 ± 0.07 | n.v.4.37 ± 0.34 | n.v.1.40 ± 0.07 | n.v.4.37 ± 0.34 | n.v.1.40 ± 0.07 | n.v.4.37 ± 0.34 | |
T0 | 0.16 | 0.65 | 0.78 | 2.01 | 0.86 | 0.3 | - | - | - | - |
T1 | 0.33 | 1.27 | 0.92 | 1.98 | 1.07 | 2.1 | - | - | 0.97 | 2.01 |
T2 | 0.58 | 1.88 | # | # | # | # | 0.98 | 2.97 | 0.95 | 1.7 |
T3 | 0.63 | 1.8 | 0.81 | 3.49 | 1.00 | 2.0 | ||||
Age at Arg treatment onset, dosage and duration of follow-up | 8 yrs, 6 mo 300 mg/kg bw/day per os24 mo | 5 yrs, 5 mo300 mg/kg bw/day per os24 mo | 8 yrs, 6 mo300 mg/kg bw/day per os24 mo | 6 yrs, 5 mo300 mg/kg bw/day per os36mo | 17 yrs300 mg/kg bw/day per os24 mo |